While the study establishes C1QA and C1QC as diagnostic biomarkers and confirms their association with atherosclerosis risk, the mechanistic pathways linking complement activation to plaque pathogenesis remain unexplained. Understanding these mechanisms is critical since atherosclerosis is a major cause of vascular dementia and stroke-related neurodegeneration. Gap type: unexplained_observation Source paper: An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis. (2023, Front Immunol, PMID:38179058)
Landscape Summary: What are the specific molecular mechanisms by which C1Q components drive atherosclerotic plaque formation and progression? is a 0.8 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
What are the specific molecular mechanisms by which C1Q components drive atherosclerotic plaque formation and progression? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: